drugset / Trial / NCT01511432
A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to evaluate the relative bioavailability, safety, and tolerability of 3 new formulations of telaprevir relative to the Incivek 375-mg tablets.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-06
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telaprevir | Small molecule | 1125 mg | Oral |